Does ADALIMUMAB Cause Oesophageal carcinoma? 99 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 99 reports of Oesophageal carcinoma have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.0% of all adverse event reports for ADALIMUMAB.
99
Reports of Oesophageal carcinoma with ADALIMUMAB
0.0%
of all ADALIMUMAB reports
31
Deaths
24
Hospitalizations
How Dangerous Is Oesophageal carcinoma From ADALIMUMAB?
Of the 99 reports, 31 (31.3%) resulted in death, 24 (24.2%) required hospitalization, and 8 (8.1%) were considered life-threatening.
Is Oesophageal carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 99 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Oesophageal carcinoma?
RANITIDINE (26,229)
ESOMEPRAZOLE (77)
CLOZAPINE (75)
METHOTREXATE (75)
OMEPRAZOLE (71)
ETANERCEPT (67)
RITUXIMAB (67)
TACROLIMUS (53)
PREDNISONE (47)
CYCLOPHOSPHAMIDE (44)
Which ADALIMUMAB Alternatives Have Lower Oesophageal carcinoma Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB